Only a tiny dent in that figure so far. I'd expect they'd be pretty nervous going into a weekend. Expect further panic up move into the close. Look at the long lean downhill for months. That's a big position to reverse.
it's all technical; First, biotech in general is hitting top and pulling back. 2nd, it's retesting the first profit-taking selloff, looks successful and at a higher level. The analyst price target of 17 is the high for the time being. I'd expect a run back to 15's before much of a pause, once biotech today stabilizes.
does that mean that it is AS effective as the surgery option? Or just that it's 1.1 sigma above "no effect". Barron's article says the analysts were pretty surprised at this price rise given the data has been out there for a while.